Reply to Heterogeneity within AML with CEBPA mutations; Only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis
Journal
British Journal of Cancer
Journal Volume
101
Journal Issue
4
Pages
738-740
Date Issued
2009
Abstract
We read with great interest the recent study by However, the reason why CEBPA single-mut patients have a poorer outcome than CEBPA double-mut patients remains unclear and a comprehensive study to evaluate the biological difference between these two groups is still lacking.
SDGs
Other Subjects
CD15 antigen; CD56 antigen; CD7 antigen; HLA DR antigen; acute granulocytic leukemia; cancer survival; cebpa gene; gene; gene mutation; human; letter; overall survival; priority journal; prognosis; protein expression; survival rate; CCAAT-Enhancer-Binding Proteins; Disease-Free Survival; DNA Mutational Analysis; Humans; Kaplan-Meiers Estimate; Leukemia, Myeloid, Acute; Mutation; Prognosis; Tumor Markers, Biological
Type
letter
